AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 37027131 — intervention group
Group type: EXPERIMENTAL
Intervention: Nurse/community health worker-delivered intervention
Number of subjects: 60
Study 37027131 — intervention group
Group type: COMPARATOR
Intervention: Standard primary care (control)
Number of subjects: 60
Study 33522249 — intervention group
Group type: EXPERIMENTAL
Intervention: Sacubitril/valsartan
Number of subjects: 8399
Study 33522249 — intervention group
Group type: COMPARATOR
Intervention: Enalapril
Number of subjects: 8399
Study 33522249 — intervention group
Group type: EXPERIMENTAL
Intervention: COPD
Number of subjects: 8399
Study 32896743 — intervention group
Group type: EXPERIMENTAL
Intervention: Online intervention (6 sessions focusing on behavioral techniques to decrease arousal and aggression)
Number of subjects: 235
Study 32896743 — intervention group
Group type: EXPERIMENTAL
Intervention: Online intervention (6 sessions)
Number of subjects: 235
Study 33412422 — intervention group
Group type: EXPERIMENTAL
Intervention: Escitalopram
Number of subjects: 14
Study 33412422 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 14
Study 32790734 — intervention group
Group type: EXPERIMENTAL
Intervention: MVS Stylet Scope
Number of subjects: 30
Study 32790734 — intervention group
Group type: COMPARATOR
Intervention: Direct laryngoscope with Miller #1 blade
Number of subjects: 30
Study 35667873 — intervention group
Group type: EXPERIMENTAL
Intervention: ONS (oral nutritional supplements) administered twice daily for 7 days prior to surgery
Number of subjects: 100
Study 33941632 — intervention group
Group type: EXPERIMENTAL
Intervention: Aquablation
Number of subjects: 0
Study 33941632 — intervention group
Group type: COMPARATOR
Intervention: Holmium laser enucleation of the prostate (HoLEP)
Number of subjects: 0
Study 34821943 — intervention group
Group type: EXPERIMENTAL
Intervention: Knotted lasso-loop mattress
Number of subjects: 18
Study 34821943 — intervention group
Group type: EXPERIMENTAL
Intervention: Knotted mattress
Number of subjects: 18
Study 34821943 — intervention group
Group type: EXPERIMENTAL
Intervention: Knotless tape repair
Number of subjects: 18
Study 35452022 — intervention group
Group type: EXPERIMENTAL
Intervention: Generalized Vestibular Rehabilitation Therapy (GVRT)
Number of subjects: 57
Study 35452022 — intervention group
Group type: EXPERIMENTAL
Intervention: Individualized Vestibular Rehabilitation Therapy (IVRT)
Number of subjects: 57
Study 33478529 — intervention group
Group type: EXPERIMENTAL
Intervention: Health education intervention based on the IMB model
Number of subjects: 372
Study 33478529 — intervention group
Group type: COMPARATOR
Intervention: Control group (health education on breastfeeding)
Number of subjects: 372
Study 32819399 — intervention group
Group type: EXPERIMENTAL
Intervention: Transthoracic esophagectomy
Number of subjects: 262
Study 32819399 — intervention group
Group type: COMPARATOR
Intervention: Transhiatal extended gastrectomy
Number of subjects: 262
Study 34710566 — intervention group
Group type: EXPERIMENTAL
Intervention: Gap Balancing (GB)
Number of subjects: 71
Study 34710566 — intervention group
Group type: COMPARATOR
Intervention: Measured Resection (MR)
Number of subjects: 71
Study 32588738 — intervention group
Group type: EXPERIMENTAL
Intervention: Single shot saphenous nerve block (SNB)
Number of subjects: 64
Study 32588738 — intervention group
Group type: COMPARATOR
Intervention: Continuous saphenous nerve block (SNB)
Number of subjects: 64
Study 32588738 — intervention group
Group type: EXPERIMENTAL
Intervention: Single shot SNB
Number of subjects: 64
Study 32588738 — intervention group
Group type: COMPARATOR
Intervention: Continuous SNB
Number of subjects: 64
Study 36315579 — intervention group
Group type: EXPERIMENTAL
Intervention: artesunate-pyronaridine
Number of subjects: 52
Study 36315579 — intervention group
Group type: COMPARATOR
Intervention: artemether-lumefantrine
Number of subjects: 52
Study 36315579 — intervention group
Group type: EXPERIMENTAL
Intervention: artesunate-amodiaquine
Number of subjects: 52
Study 36315579 — intervention group
Group type: EXPERIMENTAL
Intervention: artefenomel-ferroquine
Number of subjects: 52
Study 32605576 — intervention group
Group type: EXPERIMENTAL
Intervention: Providing information on personal genomic risk of melanoma
Number of subjects: 0
Study 35881398 — intervention group
Group type: EXPERIMENTAL
Intervention: Smartphone app-based education on prescribing intravenous fluids (group 1)
Number of subjects: 354
Study 35881398 — intervention group
Group type: COMPARATOR
Intervention: Smartphone app-based education on pain management (group 2)
Number of subjects: 354
Study 32197404 — intervention group
Group type: EXPERIMENTAL
Intervention: Intensive lifestyle intervention (ILIG)
Number of subjects: 180
Study 32197404 — intervention group
Group type: COMPARATOR
Intervention: Control group (CG)
Number of subjects: 180
Study 35437109 — intervention group
Group type: EXPERIMENTAL
Intervention: Pelvic floor muscle electrical stimulation (ES) for 8 weeks
Number of subjects: 0
Study 35437109 — intervention group
Group type: COMPARATOR
Intervention: Walking program (Control)
Number of subjects: 0
Study 34335460 — intervention group
Group type: EXPERIMENTAL
Intervention: Acupuncture
Number of subjects: 72
Study 34335460 — intervention group
Group type: COMPARATOR
Intervention: Venlafaxine (Control)
Number of subjects: 72
Study 32996434 — intervention group
Group type: EXPERIMENTAL
Intervention: Finger orthoses
Number of subjects: 14
Study 32996434 — intervention group
Group type: COMPARATOR
Intervention: No orthoses
Number of subjects: 14
Study 35186297 — intervention group
Group type: EXPERIMENTAL
Intervention: Wuda granule (WDG)
Number of subjects: 30
Study 35186297 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 30
Study 33260560 — intervention group
Group type: EXPERIMENTAL
Intervention: Yeast mannan (YM)
Number of subjects: 110
Study 33260560 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 110
Study 34115205 — intervention group
Group type: COMPARATOR
Intervention: Control (standard dietary/medical counseling)
Number of subjects: 111
Study 34115205 — intervention group
Group type: EXPERIMENTAL
Intervention: Control + smartphone fluid management application (app)
Number of subjects: 111
Study 34115205 — intervention group
Group type: EXPERIMENTAL
Intervention: Control + smart water bottle (bottle)
Number of subjects: 111
Study 33541748 — intervention group
Group type: EXPERIMENTAL
Intervention: Expedited transport
Number of subjects: 15
Study 33541748 — intervention group
Group type: COMPARATOR
Intervention: Standard care
Number of subjects: 15
Study 35674255 — intervention group
Group type: EXPERIMENTAL
Intervention: MOWHTO with ADMSC-injection
Number of subjects: 26
Study 35674255 — intervention group
Group type: COMPARATOR
Intervention: MOWHTO alone
Number of subjects: 26
Study 32679876 — intervention group
Group type: EXPERIMENTAL
Intervention: Perceived loneliness
Number of subjects: 611
Study 32679876 — intervention group
Group type: COMPARATOR
Intervention: Living with others
Number of subjects: 611
Study 32679876 — intervention group
Group type: EXPERIMENTAL
Intervention: Moderate physical exercise
Number of subjects: 611
Study 36323978 — intervention group
Group type: COMPARATOR
Intervention: robotic intraperitoneal onlay mesh (rIPOM)
Number of subjects: 100
Study 36323978 — intervention group
Group type: EXPERIMENTAL
Intervention: enhanced-view totally extraperitoneal (eTEP)
Number of subjects: 100
Study 35544084 — intervention group
Group type: EXPERIMENTAL
Intervention: Bimekizumab
Number of subjects: 1789
Study 33105372 — intervention group
Group type: EXPERIMENTAL
Intervention: SET-Test
Number of subjects: 35
Study 33105372 — intervention group
Group type: EXPERIMENTAL
Intervention: pV[Combining Dot Above]O2-PLAY
Number of subjects: 35
Study 33105372 — intervention group
Group type: EXPERIMENTAL
Intervention: pV[Combining Dot Above]O2-TEST
Number of subjects: 35
Study 33197371 — intervention group
Group type: EXPERIMENTAL
Intervention: Culturally adapted cutoff scores for Reliable Digit Span
Number of subjects: 114
Study 33197371 — intervention group
Group type: EXPERIMENTAL
Intervention: Culturally adapted cutoff scores for Phonetic Fluency Test
Number of subjects: 114
Study 33197371 — intervention group
Group type: EXPERIMENTAL
Intervention: Culturally adapted cutoff scores for Semantic Fluency Test
Number of subjects: 114
Study 33197371 — intervention group
Group type: COMPARATOR
Intervention: Non-adapted scores for embedded PVTs
Number of subjects: 114
Study 34152804 — intervention group
Group type: EXPERIMENTAL
Intervention: MSKCC-N5
Number of subjects: 630
Study 34152804 — intervention group
Group type: COMPARATOR
Intervention: rCOJEC
Number of subjects: 630
Study 32223318 — intervention group
Group type: EXPERIMENTAL
Intervention: Rivaroxaban (2.5 mg twice daily) plus aspirin (100 mg daily)
Number of subjects: 10341
Study 32223318 — intervention group
Group type: COMPARATOR
Intervention: Placebo plus aspirin (100 mg daily)
Number of subjects: 10341
Study 34019661 — intervention group
Group type: EXPERIMENTAL
Intervention: 1 mg OPK-88004 daily for 12 weeks
Number of subjects: 114
Study 34019661 — intervention group
Group type: EXPERIMENTAL
Intervention: 5 mg OPK-88004 daily for 12 weeks
Number of subjects: 114
Study 34019661 — intervention group
Group type: EXPERIMENTAL
Intervention: 15 mg OPK-88004 daily for 12 weeks
Number of subjects: 114
Study 34019661 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 114
Study 36199124 — intervention group
Group type: EXPERIMENTAL
Intervention: INCREASE diary with expectation management strategies
Number of subjects: 0
Study 36199124 — intervention group
Group type: COMPARATOR
Intervention: Cognitive exercises (originally mentioned)
Number of subjects: 0
Study 33821552 — intervention group
Group type: EXPERIMENTAL
Intervention: Induction chemotherapy followed by intensity-modulated radiotherapy (IC-RT)
Number of subjects: 448
Study 33821552 — intervention group
Group type: COMPARATOR
Intervention: Concurrent chemoradiotherapy (CCRT)
Number of subjects: 448
Study 35276965 — intervention group
Group type: EXPERIMENTAL
Intervention: Interrupted sitting (interrupting sitting every 30 min with 6−10 min of activity)
Number of subjects: 12
Study 35276965 — intervention group
Group type: COMPARATOR
Intervention: Uninterrupted sitting (sitting for ≥10 h/day with ≥7, 1 h sitting bouts each day)
Number of subjects: 12
Study 33119647 — intervention group
Group type: EXPERIMENTAL
Intervention: Musical intervention (The Mould that Changed the World)
Number of subjects: 182
Study 35285766 — intervention group
Group type: EXPERIMENTAL
Intervention: Applied Relaxation (AR) training (n=102)
Number of subjects: 277
Study 35285766 — intervention group
Group type: COMPARATOR
Intervention: Control group (CG) (n=134)
Number of subjects: 277
Study 35285766 — intervention group
Group type: EXPERIMENTAL
Intervention: Applied Relaxation (AR) training
Number of subjects: 277
Study 33331529 — intervention group
Group type: EXPERIMENTAL
Intervention: Knowledge quiz about dementias
Number of subjects: 81
Study 33331529 — intervention group
Group type: EXPERIMENTAL
Intervention: Attitude quiz towards patients afflicted with dementia
Number of subjects: 81
Study 33331529 — intervention group
Group type: EXPERIMENTAL
Intervention: Weekly working hours of the physician
Number of subjects: 81
Study 35168969 — intervention group
Group type: EXPERIMENTAL
Intervention: Multifaceted training programme (two 4-hour training sessions, dissemination of interactive educational materials, review of video-recorded consultations, individual feedback)
Number of subjects: 100
Study 35168969 — intervention group
Group type: COMPARATOR
Intervention: No intervention (control group)
Number of subjects: 100
Study 35168969 — intervention group
Group type: EXPERIMENTAL
Intervention: Multifaceted training programme
Number of subjects: 100
Study 34407339 — intervention group
Group type: EXPERIMENTAL
Intervention: Convalescent plasma with a high titer of antibodies against SARS-CoV-2
Number of subjects: 511
Study 34407339 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 511
Study 34407339 — intervention group
Group type: EXPERIMENTAL
Intervention: Convalescent plasma
Number of subjects: 511
Study 32079885 — intervention group
Group type: EXPERIMENTAL
Intervention: Volar plate fixation
Number of subjects: 90
Study 34920097 — intervention group
Group type: EXPERIMENTAL
Intervention: OC‐01 0.03 mg
Number of subjects: 123
Study 34920097 — intervention group
Group type: EXPERIMENTAL
Intervention: OC‐01 0.06 mg
Number of subjects: 123
Study 34920097 — intervention group
Group type: COMPARATOR
Intervention: Vehicle (control)
Number of subjects: 123
Study 33909728 — intervention group
Group type: EXPERIMENTAL
Intervention: Rough-surface implants
Number of subjects: 114
Study 33909728 — intervention group
Group type: COMPARATOR
Intervention: Machined implants
Number of subjects: 114
Study 33909728 — intervention group
Group type: COMPARATOR
Intervention: Nobel Biocare implants
Number of subjects: 114
Study 33909728 — intervention group
Group type: COMPARATOR
Intervention: Sweden & Martina implants
Number of subjects: 114
Study 33607371 — intervention group
Group type: EXPERIMENTAL
Intervention: Posterior rhabdosphincter reconstruction
Number of subjects: 40
Study 33607371 — intervention group
Group type: COMPARATOR
Intervention: Standard reconstruction technique
Number of subjects: 40
Study 33607371 — intervention group
Group type: EXPERIMENTAL
Intervention: Not specified
Number of subjects: 40
Study 32030723 — intervention group
Group type: EXPERIMENTAL
Intervention: Microwave therapy
Number of subjects: 11
Study 32030723 — intervention group
Group type: COMPARATOR
Intervention: Untreated controls
Number of subjects: 11
Study 36972981 — intervention group
Group type: EXPERIMENTAL
Intervention: Supramaximal high-intensity interval training (HIT)
Number of subjects: 68
Study 36972981 — intervention group
Group type: COMPARATOR
Intervention: Moderate-intensity training (MIT)
Number of subjects: 68
Study 36972981 — intervention group
Group type: EXPERIMENTAL
Intervention: Both HIT and MIT
Number of subjects: 68
Study 34620312 — intervention group
Group type: EXPERIMENTAL
Intervention: High fiber rye products
Number of subjects: 242
Study 34620312 — intervention group
Group type: COMPARATOR
Intervention: Refined wheat products
Number of subjects: 242
Study 32526210 — intervention group
Group type: EXPERIMENTAL
Intervention: Pharmacist-led care group
Number of subjects: 2718
Study 32526210 — intervention group
Group type: COMPARATOR
Intervention: Conventional care group
Number of subjects: 2718
Study 35051870 — intervention group
Group type: EXPERIMENTAL
Intervention: Branching simulations intervention
Number of subjects: 70
Study 35051870 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 70
Study 34588162 — intervention group
Group type: EXPERIMENTAL
Intervention: Early CT coronary angiography
Number of subjects: 1748
Study 34588162 — intervention group
Group type: COMPARATOR
Intervention: Standard of care only
Number of subjects: 1748
Study 34989181 — intervention group
Group type: EXPERIMENTAL
Intervention: Simulator training for knee arthrocentesis
Number of subjects: 30
Study 34989181 — intervention group
Group type: EXPERIMENTAL
Intervention: Simulator training for shoulder arthrocentesis
Number of subjects: 30
Study 34989181 — intervention group
Group type: COMPARATOR
Intervention: Simulator training
Number of subjects: 30
Study 34989181 — intervention group
Group type: EXPERIMENTAL
Intervention: Theoretical knowledge and confidence assessment
Number of subjects: 30
Study 34989181 — intervention group
Group type: EXPERIMENTAL
Intervention: Theoretical knowledge assessment
Number of subjects: 30
Study 32474602 — intervention group
Group type: EXPERIMENTAL
Intervention: GBLUP
Number of subjects: 0
Study 32474602 — intervention group
Group type: EXPERIMENTAL
Intervention: ANN
Number of subjects: 0
Study 32474602 — intervention group
Group type: EXPERIMENTAL
Intervention: GBLUP-D
Number of subjects: 0
Study 32474602 — intervention group
Group type: EXPERIMENTAL
Intervention: RF
Number of subjects: 0
Study 32474602 — intervention group
Group type: EXPERIMENTAL
Intervention: SVM
Number of subjects: 0
Study 35998839 — intervention group
Group type: EXPERIMENTAL
Intervention: Adjuvant radiotherapy (RT) alone
Number of subjects: 467
Study 35998839 — intervention group
Group type: COMPARATOR
Intervention: Adjuvant chemoradiotherapy (CRT)
Number of subjects: 467
Study 33775745 — intervention group
Group type: EXPERIMENTAL
Intervention: Risperidone
Number of subjects: 115
Study 33775745 — intervention group
Group type: EXPERIMENTAL
Intervention: Aripiprazole
Number of subjects: 115
Study 35476681 — intervention group
Group type: EXPERIMENTAL
Intervention: TRIANGLE intervention
Number of subjects: 66
Study 35476681 — intervention group
Group type: COMPARATOR
Intervention: Standard care (control)
Number of subjects: 66
Study 35476681 — intervention group
Group type: EXPERIMENTAL
Intervention: TRIANGLE intervention (per-protocol subgroup)
Number of subjects: 66
Study 35476681 — intervention group
Group type: EXPERIMENTAL
Intervention: TRIANGLE app usage
Number of subjects: 66
Study 33453703 — intervention group
Group type: EXPERIMENTAL
Intervention: Chest echography
Number of subjects: 0
Study 35005065 — intervention group
Group type: EXPERIMENTAL
Intervention: Subthalamic nucleus deep brain stimulation (STN‐DBS)
Number of subjects: 0
Study 35005065 — intervention group
Group type: EXPERIMENTAL
Intervention: Subthalamic nucleus deep brain stimulation (STN‐DBS) with multiple microelectrode recordings
Number of subjects: 0
Study 35487183 — intervention group
Group type: EXPERIMENTAL
Intervention: Cabozantinib
Number of subjects: 0
Study 35487183 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 36403344 — intervention group
Group type: EXPERIMENTAL
Intervention: Mat Pilates
Number of subjects: 74
Study 36403344 — intervention group
Group type: EXPERIMENTAL
Intervention: Belly Dance
Number of subjects: 74
Study 36403344 — intervention group
Group type: COMPARATOR
Intervention: Control (Educational Sessions)
Number of subjects: 74
Study 33928660 — intervention group
Group type: EXPERIMENTAL
Intervention: COVID-19 vaccine
Number of subjects: 0
Study 33928660 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 32527251 — intervention group
Group type: EXPERIMENTAL
Intervention: Web-based physical activity program
Number of subjects: 266
Study 34224503 — intervention group
Group type: EXPERIMENTAL
Intervention: Universidade do Bebê (UBB)
Number of subjects: 484
Study 34224503 — intervention group
Group type: COMPARATOR
Intervention: Standard care (control)
Number of subjects: 484
Study 32285847 — intervention group
Group type: EXPERIMENTAL
Intervention: General anesthesia
Number of subjects: 150
Study 32285847 — intervention group
Group type: EXPERIMENTAL
Intervention: Conscious sedation
Number of subjects: 150
Study 32175908 — intervention group
Group type: EXPERIMENTAL
Intervention: capABILITY app with trigger messages (spark and facilitator messages)
Number of subjects: 20
Study 32175908 — intervention group
Group type: COMPARATOR
Intervention: capABILITY app alone (control condition)
Number of subjects: 20
Study 32175908 — intervention group
Group type: EXPERIMENTAL
Intervention: capABILITY app for high and midusers (n=14)
Number of subjects: 20
Study 35283720 — intervention group
Group type: EXPERIMENTAL
Intervention: Mailing of urine self-sampling kit
Number of subjects: 0
Study 35283720 — intervention group
Group type: EXPERIMENTAL
Intervention: Mailing of vaginal self-sampling kit
Number of subjects: 0
Study 35283720 — intervention group
Group type: COMPARATOR
Intervention: Conventional invitation letter (control)
Number of subjects: 0
Study 33063882 — intervention group
Group type: EXPERIMENTAL
Intervention: Nalbuphine
Number of subjects: 100
Study 33063882 — intervention group
Group type: COMPARATOR
Intervention: Sufentanil
Number of subjects: 100
Study 35748937 — intervention group
Group type: EXPERIMENTAL
Intervention: Parent training intervention
Number of subjects: 160
Study 32627592 — intervention group
Group type: EXPERIMENTAL
Intervention: Baby CHAT intervention
Number of subjects: 20
Study 36153281 — intervention group
Group type: EXPERIMENTAL
Intervention: Alirocumab
Number of subjects: 18924
Study 36153281 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 18924
Study 33468144 — intervention group
Group type: EXPERIMENTAL
Intervention: Transition education program
Number of subjects: 200
Study 33468144 — intervention group
Group type: COMPARATOR
Intervention: No intervention (control group)
Number of subjects: 200
Study 35063230 — intervention group
Group type: EXPERIMENTAL
Intervention: Folic acid consumption (measured as Dietary Folate Equivalents - DFE)
Number of subjects: 101
Study 35063230 — intervention group
Group type: EXPERIMENTAL
Intervention: Flour intake
Number of subjects: 101
Study 35063230 — intervention group
Group type: EXPERIMENTAL
Intervention: Presence of at least one more child under 5 years of age
Number of subjects: 101
Study 35063230 — intervention group
Group type: EXPERIMENTAL
Intervention: Receiving the Bolsa Família Program
Number of subjects: 101
Study 32367201 — intervention group
Group type: EXPERIMENTAL
Intervention: TiN-coated CoCrMo TKA
Number of subjects: 101
Study 32367201 — intervention group
Group type: COMPARATOR
Intervention: Uncoated CoCrMo TKA
Number of subjects: 101
Study 32503365 — intervention group
Group type: EXPERIMENTAL
Intervention: Stress management counseling (individual sessions, four sessions, twice a week at 35 and 36 weeks of gestation)
Number of subjects: 46
Study 32503365 — intervention group
Group type: COMPARATOR
Intervention: Routine cares (control group)
Number of subjects: 46
Study 36481243 — intervention group
Group type: EXPERIMENTAL
Intervention: Smart Beginnings intervention
Number of subjects: 403
Study 33682268 — intervention group
Group type: COMPARATOR
Intervention: Conventional needle irrigation with 4% NaOCl (Group 1, n=15)
Number of subjects: 74
Study 33682268 — intervention group
Group type: EXPERIMENTAL
Intervention: EndoActivator with 4% NaOCl (Group 2, n=19)
Number of subjects: 74
Study 33682268 — intervention group
Group type: EXPERIMENTAL
Intervention: XP‐endo Finisher with 4% NaOCl (Group 3, n=17)
Number of subjects: 74
Study 35092868 — intervention group
Group type: EXPERIMENTAL
Intervention: HDRS Early Insomnia items
Number of subjects: 80
Study 35092868 — intervention group
Group type: EXPERIMENTAL
Intervention: HDRS Late Insomnia items
Number of subjects: 80
Study 35092868 — intervention group
Group type: EXPERIMENTAL
Intervention: HDRS Middle Insomnia items
Number of subjects: 80
Study 35092868 — intervention group
Group type: EXPERIMENTAL
Intervention: HDRS Global Insomnia score
Number of subjects: 80
Study 33705452 — intervention group
Group type: EXPERIMENTAL
Intervention: Seasonal influenza vaccine
Number of subjects: 648
Study 33705452 — intervention group
Group type: EXPERIMENTAL
Intervention: Positive influenza POCT result
Number of subjects: 648
Study 36034548 — intervention group
Group type: EXPERIMENTAL
Intervention: Iron supplementation for 3 months
Number of subjects: 80
Study 36034548 — intervention group
Group type: EXPERIMENTAL
Intervention: Iron supplementation for 6 months
Number of subjects: 80
Study 36098670 — intervention group
Group type: EXPERIMENTAL
Intervention: Deutetrabenazine (24, 48, and 72 mg)
Number of subjects: 36
Study 36098670 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 36